Skip to content
Abierto

Solicitation, total small business set-aside, first published as presolicitation

National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Innovative Concept Award Program – Fiscal Year 2025

75N91024R00013

National Institutes of Health, NIH NCI. Research and Development in the Physical, Engineering, and Life Sciences.

Awarded

Pathcision Medicine, Inc.

$299,991.00 obligated so far on USAspending

Description

As published on SAM.gov.

The National Cancer Institute is soliciting proposals from small business concerns to perform key activities to demonstrate technical feasibility and proof-of-concept for the development of highly innovative and potentially transformative technologies in the following areas: Development of therapeutic or preventative technologies for treatment or prevention of Pediatric Cancers and/or Rare Cancers.

Development of devices, diagnostic technologies, or digital health tools for treatment, detection, and diagnosis of Pediatric Cancers and/or Rare Cancers. For this solicitation rare cancers with a 5-year survival rate of less than 50 % are encouraged and rare cancers would be defined as including all the cancers listed by the NIH Genetics and Rare Diseases Information Center. The list can be found here: https://rarediseases.info.nih.gov/search-result?category=Cancer.

Access the NCI Surveillance, Epidemiology, and End Results Program (SEER) database (https://seer.cancer.gov/) for more information regarding 5-year cancer survival rates. Preliminary data is not required; however, the ideas should have sound scientific premise either based on the offeror’s own research or literature evidence. Proposals will need to identify an anticipated product that will be developed and clearly lay out the anticipated development path.

Proposals will need to clearly identify the clinical problem and cancer type(s) that the proposal will focus on with adequate justification. In addition, the offerors should propose experiments to obtain initial de-risking and proof-of-concept data. Awards will also include requirements to enhance entrepreneurship skills and to develop or refine a business model and commercialization plan.

This solicitation is a Concept Award program that could serve as a pipeline for the federal Small Business Innovation Research (SBIR) program. Background for the SBIR program can be found in the Small Business Administration’s policy directive found here: https://www.sbir.gov/sites/default/files/SBA%20SBIR_STTR_POLICY_DIRECTIVE_May2023.pdf

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
K8R9YHMX6Q31
CAGE
06A12
Vendor location
San Rafael, CA
Contract
75N91025C00011, definitive contract
Obligated
$299,991.00
Actions
2 between September 15, 2025 and September 11, 2026
Competition
Full and Open Competition After Exclusion of Sources, 55 offers received
Set-aside reported
Small Business Set Aside - Total
Described as
FY2025 SBIR Concept Clearance Award or Topic Development of Therapeutic or Preventative Technologies for Treatment or Prevention of Pediatric Cancers And/Or Rare Cancers
Match
solicitation number 75N91024R00013 equals the FPDS solicitation identifier; same awarding office 75N910 (high confidence)
UEI
MTRTYVL8N717
CAGE
01U66
Vendor location
Missouri City, TX
Contract
75N91025C00012, definitive contract
Obligated
$297,621.00
Actions
2 between September 16, 2025 and September 14, 2026
Competition
Full and Open Competition After Exclusion of Sources, 55 offers received
Set-aside reported
Small Business Set Aside - Total
Described as
FY2025 SBIR Concept Clearance Award for Topic Development of Therapeutic or Preventative Technologies for Treatment or Prevention of Pediatric Cancers And/Or Rare Cancers.
Match
solicitation number 75N91024R00013 equals the FPDS solicitation identifier; same awarding office 75N910 (high confidence)
UEI
CK6QRF2GLBT1
CAGE
9BD69
Vendor location
Watertown, MA
Contract
75N91025C00018, definitive contract
Obligated
$299,981.00
Actions
2 between August 5, 2025 and July 20, 2026
Competition
Full and Open Competition After Exclusion of Sources, 55 offers received
Set-aside reported
Small Business Set Aside - Total
Described as
SBIR Concept Award for a Novel Delivery Approach to Transform Metastatic Pancreatic Cancer Treatment and Prevention
Match
solicitation number 75N91024R00013 equals the FPDS solicitation identifier; same awarding office 75N910 (high confidence)
UEI
NR4GYWZ66HM5
CAGE
0QEA6
Vendor location
New Haven, CT
Contract
75N91025C00020, definitive contract
Obligated
$300,000.00
Actions
2 between September 10, 2025 and September 9, 2026
Competition
Full and Open Competition After Exclusion of Sources, 55 offers received
Set-aside reported
Small Business Set Aside - Total
Described as
SBIR FY25 Concept Award: Development of Engineered Trna Therapeutics for Clear Cell Renal Cell Carcinoma
Match
solicitation number 75N91024R00013 equals the FPDS solicitation identifier; same awarding office 75N910 (high confidence)
UEI
SECRMGV8SX87
CAGE
9C7V7
Vendor location
Los Altos, CA
Contract
75N91025C00021, definitive contract
Obligated
$300,000.00
Actions
2 between September 11, 2025 and September 1, 2026
Competition
Full and Open Competition After Exclusion of Sources, 52 offers received
Set-aside reported
Small Business Set Aside - Total
Described as
SBIR FY25 Concept Award: Targeting Dysfunctional Chromatin Networks in Dipg
Match
solicitation number 75N91024R00013 equals the FPDS solicitation identifier; same awarding office 75N910 (high confidence)
UEI
U33SZN8R3966
CAGE
9K6A1
Vendor location
Doylestown, PA
Contract
75N91025C00025, definitive contract
Obligated
$300,000.00
Actions
2 between September 16, 2025 and August 20, 2026
Competition
Full and Open Competition After Exclusion of Sources, 55 offers received
Set-aside reported
Small Business Set Aside - Total
Described as
SBIR FY25 Concept Award, Development of an Immunotherapy for Ewing Sarcoma Using a Novel Murine Model
Match
solicitation number 75N91024R00013 equals the FPDS solicitation identifier; same awarding office 75N910 (high confidence)
Recipient
Syzonc, Inc.
UEI
JRJ6JNJ2CHF3
CAGE
9GXP6
Vendor location
Ewing, NJ
Contract
75N91025C00027, definitive contract
Obligated
$299,878.00
Actions
3 between September 25, 2025 and September 9, 2026
Competition
Full and Open Competition After Exclusion of Sources, 55 offers received
Set-aside reported
Small Business Set Aside - Total
Described as
SBIR FY25 Concept Award, Targeting Plod2 in Undifferentiated Pleomorphic Sarcoma
Match
solicitation number 75N91024R00013 equals the FPDS solicitation identifier; same awarding office 75N910 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. March 28, 2024

    Presolicitation

    Due April 12, 2024 at 5:00 PM EDT. SAM.gov, notice 56789d3538e44d668456532c5766c190

  2. April 12, 2024

    Solicitation, originally presolicitation

    Due September 23, 2024 at 5:00 PM EDT. SAM.gov, notice 43856fb93e9042b28c10e285d3aacb89

Points of contact